Pharmafile Logo
Pharmafocus logo
Advanced Search

Latest Feature Articles

andrea_pfeifer_edit

Working Life Interview: Dr Andrea Pfeifer, Co-Founder and CEO, AC Immune

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | AC Immune, Interview, Working Life, feature, pharma

What originally set you off on your career path? Was the plan always to go into the pharma and biotech …

Feature

How AI is making clinical trials more accurate and affordable

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | AI, AI Clinical Trials, Apple, Apple Watch., apple watch, clinical trials

Clinical trials are one of the longest and most expensive steps of bringing a drug to market. Conor Kavanagh investigates …

Feature

Insider Interview: Reducing the risk of adverse cardiovascular events

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | AstraZeneca, Insider Interview, cardiovascular, heart disease, pharma

Rodrigo Gribble, Vice President Cardiovascular at AstraZeneca, breaks down recently published data from the PEGASUS trial of ticagrelor, a potential …

Feature
lynn_taylor_updated_headshot_web

Realising the potential of greater collaboration for women living with cancer

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Cancer, Merck KGaA, feature, pharma, women

Following the launch of a new global report, ‘Supporting women with cancer’, Lynn Talyroe, Senior Vice President, Head of Healthcare …

Feature
gettyimages-952692342-5c16809146e0fb0001dee456

Collaborating to realise the potential of precision medicine

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Precision Medicine, feature, pharma

Healthcare is an evolving continuum, and while traditional strategies have seen improvements to patient outcomes over time, voices in the …

Feature
jp-kress_mor

Working Life Interview: Jean-Paul Kress, CEO of MorphoSys

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Working Life, feature, morphosys, pharma

With a medical doctorate as well as degrees in pharmacology and immunology under your belt, was your path always to …

Feature
insider_interview_andrew_roach

A new weapon against Parkinson’s-related psychosis

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Parkinson's disease, cannabidiol, cannabis, feature, pharma

Dr Arthur Roach, Director of Research at the charity Parkinson’s UK, discusses new trials on cannabidiol in the treatment of …

Feature
shutterstock_138095450

Transactions in the pharma sector: Through the EU merger review looking-glass

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | EU, feature, mergers & acquisitions, pharma

With mergers and acquisitions back in full swing after a period of drought, Alec Burnside (Partner) and Delphine Strohl (Associate) …

Feature
image3

Patient experience: Living with desmoid fibromatosis

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | desmoid fibrosis, feature, patient experience, pharma, rare disease

Lisa Pascoe lives with a rare, benign desmoid tumour in her abdomen. She opens up to Pharmafocus on her diagnosis …

Feature
sang-jin_pak

Exclusive interview: Samsung Bioepis’ Sang-Jin Pak on the rise of biosimilars

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Samsung Bioepis, biosimilars, pharma

Following on from our focus on biosimilars in our feature last week, you can read Nikhil Patel’s interview with Sang-Jin …

Feature

The coming age of biosimilars

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | biosimilars, feature, pharma

With more and more biosimilars securing approval and the sheer potential value they have to offer for healthcare systems around …

Feature
capture

Bringing the clinical trial home

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | clinical trials, feature, research

Clinical trials are the backbone of healthcare and drug research, but many key patient populations have in the past been …

Feature

Working Life Interview: Alison Muir, Oncology Product Strategy Director at Roche

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Roche, Working Life, feature, pharma

You studied biology at Liverpool John Moores University before heading straight to GSK in 1990 as a Sales Representative; was …

Feature

Redefining the value of medicines with patients at the centre

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Takeda, health economics and outcomes research, market access, pharma

Liz Lewis, Head of Global Oncology Patient Value, Policy and Access at Takeda Oncology, discusses the importance and challenges of …

Feature
shutterstock_273326141

Transactions in the pharma sector: Through the EU merger review looking-glass

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | mergers, mergers and acquisitions, pharma

With mergers and acquisitions back in full swing after a period of drought, Alec Burnside (Partner) and Delphine Strohl (Associate) …

Feature
Load more Feature Articles
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026